UPDATE 1-BioDelivery, Endo painkiller effective in study

July 7, 2014 11:51 AM

4 0

July 7 (Reuters) - Endo International Plc and BioDelivery Sciences International Inc said their experimental pain drug was found effective in a second late-stage trial.

BioDelivery's shares jumped about 18 percent to $14.10 before the bell. Endo shares were untraded.

Also read: Eurozone Finance Ministers Try to Lure IMF Back Into Greece Bailout

Read more

To category page